# US 8,278,043 B2 · Methods and materials related to grey alleles

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,278,043 B2
- Document ID: US8278043B2
- Status: Granted
- Kind: B2
- Application number: 12/663,138
- Filed: 2008-06-05
- Published: 2010-11-11
- Granted: 2012-10-02
- Earliest claimed: 2007-06-05
- Assignees: Melica HB
- Inventors: Leif Andersson; Gerli Rosengren Pielberg; Anna Olegovna Golovko; Kjell Robert Johan Lennartsson; Carl-Henrik Heldin
- Web page: https://patentgrep.com/patent/US8278043B2

## CPC

- C12Q 1/6881: for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
- A61P 35/00: Antineoplastic agents
- C12Q 1/6886: for cancer (immunoassay for cancer G01N33/575)
- C12Q 2600/124: Animal traits, i.e. production traits, including athletic performance or the like
- C12Q 2600/136: Screening for pharmacological compounds
- C12Q 2600/156: Polymorphic or mutational markers
- C12Q 2600/158: Expression markers
- C12Q 2600/172: Haplotypes
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

This document relates to methods and materials for determining whether or not a horse contains a Grey allele. For example, diagnostic methods such as nucleic acid-based detection methods and materials such as nucleic acid probes and primer pairs that can be used to determine whether or not a horse contains a duplication in intron 6 of STX17 nucleic acid are provided. This document also relates to methods and materials for treating a mammal having or being likely to develop cancer (e.g., benign, malignant, or metastatic cancer). For example, methods and materials for treating cancer in a mammal by administering an agent having the ability to reduce expression of an STX17 polypeptide and/or an NR4A polypeptide (e.g., an NR4A1, NR4A2, or NR4A3 polypeptide) in the mammal are provided.

## Claims

### Claim 1

A method for assisting a horse breeder or horse owner in assessing a horse for the presence of a Grey allele, wherein said method comprises:
(a) sequencing a portion of intron 6 of STX17 nucleic acid of said horse to determine whether or not said horse comprises a duplication in said intron 6,
(b) classifying said horse as containing a Grey allele if said horse comprises said duplication, and
(c) classifying said horse as lacking a Grey allele if said horse does not comprise said duplication.

### Claim 2 (depends on 1)

The method of claim 1, wherein said horse is a foal.

### Claim 3 (depends on 1)

The method of claim 1, wherein said horse comprises black, brown, or chestnut hair.

### Claim 4 (depends on 1)

The method of claim 1, wherein said method comprises determining whether or not said horse is homozygous for said duplication.

### Claim 5 (depends on 4)

The method of claim 4, wherein said method comprises classifying said horse as being homozygous for said Grey allele if said horse is homozygous for said duplication.

### Claim 6 (depends on 1)

The method of claim 1, wherein said method comprises determining whether or not said horse is heterozygous for said duplication.

### Claim 7 (depends on 6)

The method of claim 6, wherein said method comprises classifying said horse as being heterozygous for said Grey allele if said horse is heterozygous for said duplication.

### Claim 8

A method for assisting a horse breeder or horse owner in assessing a horse for the presence of a Grey allele, wherein said method comprises:
(a) using a nucleic acid probe capable of detecting a breakpoint of a duplication in intron 6 of STX17 nucleic acid to determine whether or not said horse comprises said duplication,
(b) classifying said horse as containing a Grey allele if said horse comprises said duplication, and
(c) classifying said horse as lacking a Grey allele if said horse does not comprise said duplication.

### Claim 9 (depends on 8)

The method of claim 8, wherein said nucleic acid probe comprises the nucleic acid sequence set forth in SEQ ID NO:32.

### Claim 10 (depends on 8)

The method of claim 8, wherein said horse is a foal.

### Claim 11 (depends on 8)

The method of claim 8, wherein said horse comprises black, brown, or chestnut hair.

### Claim 12 (depends on 8)

The method of claim 8, wherein said method comprises determining whether or not said horse is homozygous for said duplication.

### Claim 13 (depends on 12)

The method of claim 12, wherein said method comprises classifying said horse as being homozygous for said Grey allele if said horse is homozygous for said duplication.

### Claim 14 (depends on 8)

The method of claim 8, wherein said method comprises determining whether or not said horse is heterozygous for said duplication.

### Claim 15 (depends on 14)

The method of claim 14, wherein said method comprises classifying said horse as being heterozygous for said Grey allele if said horse is heterozygous for said duplication.

### Claim 16

A method for assisting a horse breeder or horse owner in assessing a horse for the presence of a Grey allele, wherein said method comprises:
(a) using a nucleic acid primer pair capable of amplifying nucleic acid comprising a breakpoint of a duplication in intron 6 of STX17 nucleic acid to determine whether or not said horse comprises said duplication,
(b) classifying said horse as containing a Grey allele if said horse comprises said duplication, and
(c) classifying said horse as lacking a Grey allele if said horse does not comprise said duplication.

### Claim 17 (depends on 16)

The method of claim 16, wherein said horse is a foal.

### Claim 18 (depends on 16)

The method of claim 16, wherein said horse comprises black, brown, or chestnut hair.

### Claim 19 (depends on 16)

The method of claim 16, wherein said method comprises determining whether or not said horse is homozygous for said duplication.

### Claim 20 (depends on 19)

The method of claim 19, wherein said method comprises classifying said horse as being homozygous for said Grey allele if said horse is homozygous for said duplication.

### Claim 21 (depends on 16)

The method of claim 16, wherein said method comprises determining whether or not said horse is heterozygous for said duplication.

### Claim 22 (depends on 21)

The method of claim 21, wherein said method comprises classifying said horse as being heterozygous for said Grey allele if said horse is heterozygous for said duplication.
